Doctor quizzed about drug info discussions with investors outside of SAC

Your Health Matters

Former University of Michigan neurology professor Dr. Sidney Gilman, exits the U.S. Attorney's office in Manhattan in New YorkBy Nate Raymond NEW YORK (Reuters) – A doctor who says he leaked details of a clinical drug trial to SAC Capital Advisors portfolio manager Mathew Martoma also discussed the drug under development with other investors, according to documents displayed in court on Thursday. But Sidney Gilman, who is testifying as a government witness in Martoma's insider trading trial, said that unlike his interactions with Martoma, he did not recall many of his meetings with the other investors. "Recalling the contents of each one is a difficult task," Gilman said in New York federal court.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave